BPH Global secures $1 million strategic placement to accelerate Indonesian seaweed expansion
BPH Global (ASX: BP8) has completed a $1.0 million capital raise to scale its BPH Global Indonesian Seaweed Investment operations. The placement was completed at $0.002 per share with no discount to market price, introducing new long-term shareholders aligned with the Company’s growth strategy. The raise follows record monthly sales performance since operations commenced in May 2025, positioning the Company to increase trading volumes and expand export activity from its established Makassar facility.
The placement comprises 500 million new fully paid ordinary shares issued to sophisticated and professional investors. Participants will receive one free attaching option for every two shares, exercisable at $0.004 with a three-year expiry, subject to shareholder approval expected at a general meeting in April 2026.
Completion at market price, rather than a discounted level, signals investor confidence in the business model at current valuation. The Company delivered its highest monthly sales result in month 6 and achieved its second highest monthly result in month 8 since commencing seaweed trading operations in May 2025, evidencing accelerating commercial momentum and increasing counterparty demand.
Where the funds will go
The $1.0 million raise (before costs) will be deployed across operational scale-up, research and development, and working capital requirements. The majority of proceeds are directed toward revenue-generating activities rather than infrastructure development, reflecting the Company’s shift from platform establishment to commercial execution.
| Use of Funds | Allocation |
|---|---|
| Indonesian seaweed operations | $600,000 |
| Research and development | $200,000 |
| Working capital | $140,000 |
| Costs of the offer | $60,000 |
60% of proceeds are allocated to Indonesian-based seaweed operations, demonstrating capital discipline and focus on scaling proven commercial activity. The allocation supports expanded procurement, increased export throughput and continued customer engagement, with growth executed in a manner aligned to realised demand and operational capacity.
What is seaweed trading and why does it matter?
BPH Global operates a trading platform in Indonesia, sourcing seaweed locally and exporting to international buyers. The model leverages Indonesia’s position as a major global seaweed producer, providing access to reliable supply for redistribution to markets where demand for seaweed in food, agriculture and industrial applications continues to grow.
Trading businesses generate revenue from volume throughput. Scaling procurement and export capacity directly increases top-line revenue. The model is asset-light compared to cultivation or manufacturing, reducing capital intensity and enabling faster scaling once infrastructure and regulatory approvals are secured.
For BP8, the trading platform serves as a revenue-generating foundation while the Company evaluates opportunities in higher-margin activities, including independently executed sales channels and selective downstream initiatives over time.
Operational infrastructure already in place
Execution risk has been materially de-risked through the establishment of core infrastructure and regulatory approvals. BP8 operates from a fully commissioned warehouse facility in Makassar and holds a valid Indonesian Government seaweed export licence, providing the operating platform required to scale volumes immediately without major capital expenditure on facilities or permits.
The established infrastructure enables the Company to respond efficiently to increasing demand while maintaining logistics reliability, quality control and counterparty confidence.
- Commissioned warehouse facility in Makassar
- Valid Indonesian Government export licence
- Logistics and quality control systems operational
Many early-stage companies raise capital to build infrastructure. BP8 has completed that phase, positioning this placement as funding for growth rather than construction. The operational readiness reduces time-to-revenue risk and allows capital deployment to focus on volume expansion across an established platform.
Sales momentum validates the model
The Company delivered its record monthly sales performance in month 6 and achieved its second highest monthly result in month 8 since commencing Indonesian seaweed trading operations in May 2025. The results evidence accelerating commercial momentum, increasing counterparty demand and growing throughput across the Indonesian trading platform.
Consecutive strong sales months suggest the trading platform is gaining traction with buyers, reducing customer concentration risk over time. While the Company has not disclosed profitability or cash flow positive status, the sales trajectory provides validation of market demand and operational execution since launch.
Pathway to higher margins
BP8 aims to improve margins over time through two strategic levers: increasing the proportion of independently executed sales (reducing reliance on third parties) and selectively progressing downstream initiatives. The Company will continue to evaluate opportunities to enhance margins by transitioning toward structurally higher-margin revenue streams, supporting long-term value creation.
This represents a medium-term objective. The Company has not claimed margin expansion has occurred to date. Current focus remains on scaling core trading volumes through expanded procurement and increased export throughput, with margin improvement initiatives progressed in a staged and risk-managed manner aligned to operational capacity.
Trading margins in commodities are typically thin. Moving toward proprietary sales channels and downstream value-add, such as processing or branded products, can structurally improve profitability. BP8’s approach balances near-term revenue growth with optionality in higher-value segments, preserving cash while maintaining exposure to multiple value drivers.
Chairman commentary
Paul Stephenson, Non-Executive Chairman
“This strategic investment follows BP8’s record month 6 trading performance and a strong month 8 trading rebound and represents an important milestone in the Company’s transition from platform establishment to scaled commercial execution.”
The placement marks a shift from infrastructure development to commercial scale-up, with funding directed toward increasing volumes across an operating platform that has demonstrated market demand. Stephenson noted the result reflects growing counterparty demand and provides further validation of the operating model BP8 has built in Indonesia since commencing trading in May 2025.
What comes next for BP8
Near-term priorities centre on scaling volumes and expanding export activity from the Makassar facility. The Company will also continue advancing longer-term biotechnology and functional nutrition initiatives in a staged and risk-managed way, preserving optionality while maintaining focus on core trading operations. An extraordinary general meeting is expected in April 2026 to seek shareholder approval for the issue of placement options to investors and brokers.
- Scale core trading volumes through expanded procurement
- Increase export throughput from Makassar facility
- Progress margin improvement initiatives
- Convene shareholder meeting in April 2026 for option approvals
- Advance biotechnology and functional nutrition opportunities in parallel
The Company is balancing near-term revenue growth with optionality in higher-value segments. This staged approach preserves cash while maintaining exposure to multiple value drivers, with working capital deployment closely aligned to realised demand and operational capacity. BP8 enters 2026 with established operating infrastructure, secured regulatory approvals and a strengthened balance sheet, providing a foundation to support continued execution across its Indonesian seaweed platform.
Want the Next Healthcare Breakout in Your Inbox?
Join 20,000+ investors getting FREE breaking ASX news delivered within minutes of release, complete with in-depth analysis. Click the “Free Alerts” button at Big News Blast to receive real-time alerts the moment market-moving announcements hit the ASX across Healthcare, Tech, Finance and beyond.